0001415889-22-002868.txt : 20220310 0001415889-22-002868.hdr.sgml : 20220310 20220310204606 ACCESSION NUMBER: 0001415889-22-002868 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220308 FILED AS OF DATE: 20220310 DATE AS OF CHANGE: 20220310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Englese Thomas CENTRAL INDEX KEY: 0001825799 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39577 FILM NUMBER: 22730896 MAIL ADDRESS: STREET 1: C/O AZIYO BIOLOGICS, INC. STREET 2: 12510 PROSPERITY DRIVE, SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 FORMER NAME: FORMER CONFORMED NAME: Englese Tom DATE OF NAME CHANGE: 20200923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AZIYO BIOLOGICS, INC. CENTRAL INDEX KEY: 0001708527 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474790334 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12510 PROSPERITY DRIVE STREET 2: SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 BUSINESS PHONE: 240-247-1143 MAIL ADDRESS: STREET 1: 12510 PROSPERITY DRIVE STREET 2: SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 4 1 form4-03102022_050356.xml X0306 4 2022-03-08 0001708527 AZIYO BIOLOGICS, INC. AZYO 0001825799 Englese Thomas C/O AZIYO BIOLOGICS, INC. 12510 PROSPERITY DRIVE, SUITE 370 SILVER SPRING MD 20904 false true false false CHIEF COMMERCIAL OFFICER Class A Common Stock 2022-03-08 4 M 0 938 0 A 6883 D Class A Common Stock 2022-03-10 4 S 0 276 D 6607 D Stock Option (Right to Buy) 5.08 2022-03-08 4 A 0 31000 0 A 2032-03-08 Class A Common Stock 31000 31000 D Restricted Stock Units 2022-03-08 4 A 0 8700 0 A Class A Common Stock 8700 8700 D Restricted Stock Units 2022-03-08 4 M 0 938 0 D Class A Common Stock 938 2812 D Restricted Stock Units 2022-03-08 4 A 0 15390 0 A Class A Common Stock 15390 15390 D Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis. Includes 857 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.16 to $5.34. The Reporting Person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock. The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024. On March 8, 2021, the Reporting Person was granted 3,750 restricted stock units, vesting in four substantially equal annual installments beginning in March 8, 2022. The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date. /s/ Jeffrey Hamet, Attorney-in-Fact for Thomas Englese 2022-03-10